资讯

Applied Clinical Trials Online17 小时
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell ...
In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent ...
Applied Clinical Trials Online3 小时
Removing Financial Barriers to Boost Trial Diversity
In this video interview, Heather Horville, solutions consultant at Greenphire, explains how upfront reimbursement, travel stipends, and flexible support services can empower more patients—especially ...
Applied Clinical Trials Online23 小时
KEYNOTE-689 Trial Shows Perioperative Keytruda Significantly Improves Survival in ...
Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care radiotherapy improves event-free survival in patients with resectable, locally ...